Preparation methods for a novel generation of biological safe KLH products used for cancer treatment, for the development of conjugated therapeutic vaccines and as challenging agents
Ortwin Kottwitz,Thomas Stiefel,Shammana N. Muddukrishna
申请号：
US15318286
公开号：
US10800820B2
申请日:
2014.06.12
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to the provision of a biologically safe hemolymph sera, preferably hemocyanin, more preferably KLH (keyhole limpet hemocyanin). The hemocyanin is purified using anion exchange chromatography.
